line
Japanese Society for Palliative Medicine
News Letter No.91
日本緩和医療学会ニューズレター
May 2021  91
Journal Watch
緩和ケアに関する論文レビュー
名古屋大学大学院医学系研究科 総合保健学専攻高度実践看護開発学講座
佐藤 一樹

対象雑誌:N Engl J Med, Lancet, Lancet Oncol, JAMA, JAMA Intern Med, JAMA Oncol, BMJ, Ann Intern Med, J Clin Oncol, Ann Oncol, Eur J Cancer, Br J Cancer, Cancer

対象期間:2020年12月〜2021年2月刊行分

いわゆる“トップジャーナル”に掲載された緩和ケアに関する最新論文を広く紹介します。


【N Engl J Med. 2020;383(23-27); 2021;384(1-8)】
1. ICUでの生命維持治療中止し死亡確認後の心拍再開
Dhanani S, Hornby L, van Beinum A, Scales NB, Hogue M, Baker A, et al. Resumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures. N Engl J Med. 2021;384(4):345-52. [PMID: 33503343]

【Lancet. 2020;396(10265-10267), 397(10268-10276)】
なし

【Lancet Oncol.2020;21(12), 2021;22(1-2)】
2. 小児・AYA世代の女性がん患者の妊孕性温存の推奨
Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22(2):e45-e56. [PMID: 33539753]
3. 小児・AYA世代の男性がん患者の妊孕性温存の推奨
Mulder RL, Font-Gonzalez A, Green DM, Loeffen EAH, Hudson MM, Loonen J, et al. Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22(2):e57-e67. [PMID: 33539754]
4. 小児・AYA世代がん患者の妊孕性温存のコミュニケーションと倫理的配慮の推奨
Mulder RL, Font-Gonzalez A, van Dulmen-den Broeder E, Quinn GP, Ginsberg JP, Loeffen EAH, et al. Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22(2):e68-e80. [PMID: 33539755]

【JAMA. 2020;324(21-24), 2021;325(1-8)】
5. 医療用大麻の運転能力への影響:無作為化比較試験
Arkell TR, Vinckenbosch F, Kevin RC, Theunissen EL, McGregor IS, Ramaekers JG. Effect of Cannabidiol and Delta9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. JAMA. 2020;324(21):2177-86. [PMID: 33258890]

【JAMA Intern Med. 2020;6(12), 2021;7(1-2)】
6. 米国の高齢終末期患者での非侵襲的・侵襲的人工呼吸の2000〜2017年の傾向
Sullivan DR, Kim H, Gozalo PL, Bunker J, Teno JM. Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life. JAMA Intern Med. 2021;181(1):93-102. [PMID: 33074320]
7. 線維筋痛症患者の鎮痛治療とQOLシステマティックレビュー
Mascarenhas RO, Souza MB, Oliveira MX, Lacerda AC, Mendonca VA, Henschke N, et al. Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2021;181(1):104-12. [PMID: 3104162]
8. 老年症候群の複数徴候保持者での安楽死・自殺ほう助のオランダでの実態調査
van den Berg V, van Thiel G, Zomers M, Hartog I, Leget C, Sachs A, et al. Euthanasia and Physician-Assisted Suicide in Patients With Multiple Geriatric Syndromes. JAMA Intern Med. 2021;181(2):245-50. [PMID: 33284324]

【JAMA Oncol. 2020;180(12), 2021;181(1-2)】
9. COVID-19パンデミックによるがん治療の遅れの予後への影響
Hartman HE, Sun Y, Devasia TP, Chase EC, Jairath NK, Dess RT, et al. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic. JAMA Oncol. 2020;6(12):1881-9. [PMID: 33119036]
10. 予後予測に基づく医療者リマインド介入によるACP話し合いへの効果:ステップウェッジクラスター無作為化試験
Manz CR, Parikh RB, Small DS, Evans CN, Chivers C, Regli SH, et al. Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Oncol. 2020:e204759. [PMID: 33057696]
11. 妊孕性温存の有無での乳がんサバイバーの妊娠予後の比較
Marklund A, Lundberg FE, Eloranta S, Hedayati E, Pettersson K, Rodriguez-Wallberg KA. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation. JAMA Oncol. 2021;7(1):86-91. [PMID: 33211089]
12. トランスジェンダーのがん患者の特徴と治療と予後(短報)
Burns ZT, Bitterman DS, Perni S, Boyle PJ, Guss CE, Haas-Kogan DA, et al. Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With Cancer. JAMA Oncol. 2021;7(1):e205671. [PMID: 33180096]
13. 米国のがんに関する災害時ケア基準(レター)
Hantel A, Marron JM, Casey M, Kurtz S, Magnavita E, Abel GA. US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. JAMA Oncol. 2021;7(2):199-205. [PMID: 33270132]
14. COVID-19感染がん患者の特徴と予後
Wang Q, Berger NA, Xu R. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncol. 2021;7(2):220-7. [PMID: 33300956]
15. 白血病での早期緩和ケア介入:無作為化比較試験
El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb JA, Jackson VA, Campbell TC, et al. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial. JAMA Oncol. 2021;7(2):238-45. [PMID: 33331857]
16. がん骨転移に対するゾレドロン酸治療での顎骨壊死の発症率
Van Poznak CH, Unger JM, Darke AK, Moinpour C, Bagramian RA, Schubert MM, et al. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA Oncol. 2021;7(2):246-54. [PMID: 33331905]
17. COVID-19パンデミック禍のドイツのがん患者のQOLの一般集団との比較
van de Poll-Franse LV, de Rooij BH, Horevoorts NJE, May AM, Vink GR, Koopman M, et al. Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES Registry. JAMA Oncol. 2021;7(2):279-84. [PMID: 33237294]
18. サハラ以南アフリカでの乳がんで母を亡くした子の疫学
Galukande M, Schuz J, Anderson BO, Zietsman A, Adisa C, Anele A, et al. Maternally Orphaned Children and Intergenerational Concerns Associated With Breast Cancer Deaths Among Women in Sub-Saharan Africa. JAMA Oncol. 2021;7(2):285-9. [PMID: 33355599]
19. 進行がん患者の息切れに対する非薬物療法:システマティックレビュー
Gupta A, Sedhom R, Sharma R, Zhang A, Waldfogel JM, Feliciano JL, et al. Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic Review. JAMA Oncol. 2021;7(2):290-8. [PMID: 33211072]

【BMJ. 2020; 371(8271-8273), 372(8274-8278)】
20. 腰痛と変形性関節痛に対する抗うつ薬の有効性と安全性:システマティックレビュー
Ferreira GE, McLachlan AJ, Lin CC, Zadro JR, Abdel-Shaheed C, O'Keeffe M, et al. Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis. BMJ. 2021;372:m4825. [PMID: 33472813]
21. 医療用大麻の販売店数とオピオイド関連死の米国での地域相関研究
Hsu G, Kovacs B. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study. BMJ. 2021;372:m4957. [PMID: 33504472]
22. 妊娠初期のオピオイド鎮痛薬処方と児の先天奇形との関連
Bateman BT, Hernandez-Diaz S, Straub L, Zhu Y, Gray KJ, Desai RJ, et al. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021;372:n102. [PMID: 33568363]

【Ann Intern Med. 2020;174(11-12), 2021;175(1-2)】
23. 妊婦へのオピオイド鎮痛薬と向精神薬の処方の米国の2001〜2015年の推移
Venkatesh KK, Pate V, Boggess KA, Jones HE, Funk MJ, Smid MC. Trends in Opioid and Psychotropic Prescription in Pregnancy in the United States From 2001 to 2015 in a Privately Insured Population : A Cross-sectional Study. Ann Intern Med. 2020;173(11 Suppl):S19-S28. [PMID: 33253018]
24. 米国食品医薬品局FDAで1997〜2018年に承認されたオピオイド鎮痛薬の重要なエビデンス
Heyward J, Moore TJ, Chen J, Meek K, Lurie P, Alexander GC. Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018. Ann Intern Med. 2020;173(12):956-63. [PMID: 32986486]
25. 急性の座骨神経痛に対する理学療法紹介の効果:無作為化比較試験
Fritz JM, Lane E, McFadden M, Brennan G, Magel JS, Thackeray A, et al. Physical Therapy Referral From Primary Care for Acute Back Pain With Sciatica : A Randomized Controlled Trial. Ann Intern Med. 2021;174(1):8-17. [PMID: 33017565]

【J Clin Oncol. 2020;38(34-36), 2021;39(1-6)】
26. 進行期食道がん患者に対する早期多職種支持療法介入の無作為化比較試験
Lu Z, Fang Y, Liu C, Zhang X, Xin X, He Y, et al. Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial. J Clin Oncol. 2021;39(7):748-56. [PMID: 33417481]
27. 高齢乳がん患者の化学療法の毒性予測モデルの妥当性
Magnuson A, Sedrak MS, Gross CP, Tew WP, Klepin HD, Wildes TM, et al. Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer. J Clin Oncol. 2021;39(6):608-18. [PMID: 33444080]
28. 頭頚部がん患者の救急外来利用・計画外入院と症状との関連
Noel CW, Sutradhar R, Zhao H, Delibasic V, Forner D, Irish JC, et al. Patient-Reported Symptom Burden as a Predictor of Emergency Department Use and Unplanned Hospitalization in Head and Neck Cancer: A Longitudinal Population-Based Study. J Clin Oncol. 2021;39(6):675-84. [PMID: 33405964]
29. がん化学療法の有害事象のオンライン患者自己報告システムのQOLに対する無作為化比較試験
Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, et al. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. J Clin Oncol. 2021;39(7):734-47. [PMID: 33417506]
30. 精巣がん長期サバイバーの精神科受診リスク
Raphael MJ, Gupta S, Wei X, Peng Y, Soares CN, Bedard PL, et al. Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study. J Clin Oncol. 2021;39(7):779-86. [PMID: 33507821]

【Ann Oncol. 2020;31(12), 2021;32(1-2)】
31.骨転移治療:ESMO臨床実践ガイドライン
Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, et al. Bone health in cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31(12):1650-63. [PMID: 32801018]
32.若年がん患者の妊孕性温存と治療後の妊娠:ESMO臨床実践ガイドライン
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines(dagger). Ann Oncol. 2020;31(12):1664-78. [PMID: 32976936]
33. 抗がん剤による皮膚障害の予防と治療:ESMO臨床実践ガイドライン
Lacouture ME, Sibaud V, Gerber PA, van den Hurk C, Fernandez-Penas P, Santini D, et al. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines(). Ann Oncol. 2021;32(2):157-70. [PMID: 33248228]
34. 原発性・転移性脳腫瘍の認知機能・血管合併症の予防と治療:EANO-ESMO臨床実践ガイドライン
Roth P, Pace A, Le Rhun E, Weller M, Ay C, Cohen-Jonathan Moyal E, et al. Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up. Ann Oncol. 2021;32(2):171-82. [PMID: 33246022]

【Eur J Cancer. 2020;141, 2021;142-144】
35. 免疫チェックポイント阻害薬での感染症のリスク因子
Karam JD, Noel N, Voisin AL, Lanoy E, Michot JM, Lambotte O. Infectious complications in patients treated with immune checkpoint inhibitors. Eur J Cancer. 2020;141:137-42. [PMID: 33137589]
36. 免疫チェックポイント阻害薬での重度の神経内分泌有害事象とインターロイキン17
Mazzarella L, Giugliano S, D'Amico P, Belli C, Duso BA, Rescigno M, et al. Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity. Eur J Cancer. 2020;141:218-24. [PMID: 33186857]
37. 免疫療法中の副腎皮質ステロイド使用の総説
Aldea M, Orillard E, Mansi L, Marabelle A, Scotte F, Lambotte O, et al. How to manage patients with corticosteroids in oncology in the era of immunotherapy? Eur J Cancer. 2020;141:239-51. [PMID: 33212339]
38. COVID-19の重症度とがん治療予後の関連:システマティックレビュー
Yekeduz E, Utkan G, Urun Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer. 2020;141:92-104. [PMID: 33130550]
39. 固形がん患者での副腎皮質ステロイド使用と予後:システマティックレビュー
Petrelli F, Bukovec R, Perego G, Luisa R, Luciani A, Zaniboni A, et al. Association of steroid use with survival in solid tumours. Eur J Cancer. 2020;141:105-14. [PMID: 33130548]
40. 骨転移に対する骨修飾薬の投与間隔4週と12週の無作為化比較試験
Clemons M, Ong M, Stober C, Ernst S, Booth C, Canil C, et al. A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer. Eur J Cancer. 2021;142:132-40. [PMID: 33023785]
41. ワクチン接種の乳がん・卵巣がんに対する有効性:システマティックレビュー
Dafni U, Martin-Lluesma S, Balint K, Tsourti Z, Vervita K, Chenal J, et al. Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis. Eur J Cancer. 2021;142:63-82. [PMID: 33221598]
42. 20〜49歳でのがん罹患の欧州での1998〜2012年の推移
Scelo G, Maule MM, Richiardi L. Cancers emerging early in adulthood: Analysis of trends and patterns in European cancer registries. Eur J Cancer. 2021;143:33-9. [PMID: 33278772]
43. 直腸がん術前化学療法でのオキサリプラチン有無での術後のQOLの比較
Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, et al. Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial. Eur J Cancer. 2021;144:281-90. [PMID: 33383348]

【Br J Cancer. 2020;123(12), 2021;124(1-4)】
44. 米国でのがん治療の人種間差の総説
Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124(2):315-32. [PMID: 32901135]

【Cancer. 2020;126(17-22)】
45. 途上国での小児がん患者・家族・医療者のコミュニケーションと意思決定のスコーピングレビュー
Graetz DE, Garza M, Rodriguez-Galindo C, Mack JW. Pediatric cancer communication in low- and middle-income countries: A scoping review. Cancer. 2020;126(23):5030-9. [PMID: 32991761]
46. COVID-19 併発の血液がん患者の臨床的特徴と予後
Cattaneo C, Daffini R, Pagani C, Salvetti M, Mancini V, Borlenghi E, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19. Cancer. 2020;126(23):5069-76. [PMID: 32910456]
47. 頭頚部がん患者の口腔内の細菌の状況と治療関連の口内炎の関連
Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, et al. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 2020;126(23):5124-36. [PMID: 32888342]
48. 高齢消化器がん患者の高齢者総合機能評価での栄養評価とQOLの関連
Williams GR, Al-Obaidi M, Dai C, Mir N, Challa SA, Daniel M, et al. Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies. Cancer. 2020;126(23):5147-55.: [PMID: 32885848]
49. がん患者の禁煙中断予防の無作為化比較試験
Simmons VN, Sutton SK, Meltzer LR, Martinez U, Palmer AM, Meade CD, et al. Preventing smoking relapse in patients with cancer: A randomized controlled trial. Cancer. 2020;126(23):5165-72. [PMID: 32902856]
50. 化学療法後認知機能低下のあるがん患者の認知リハビリテーションの無作為化比較試験
Dos Santos M, Hardy-Leger I, Rigal O, Licaj I, Dauchy S, Levy C, et al. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial. Cancer. 2020;126(24):5328-36. [PMID: 32996583]
51. 造血幹細胞移植看護の認知行動療法の介入効果へのコーピングと自己効力感の媒介効果
Jacobs JM, Nelson AM, Traeger L, Waldman L, Nicholson S, Jagielo AD, et al. Enhanced coping and self-efficacy in caregivers of stem cell transplant recipients: Identifying mechanisms of a multimodal psychosocial intervention. Cancer. 2020;126(24):5337-46. [PMID: 33026658]
52. 小児がん長期サバイバーの希死念慮と自殺企図
Lubas MM, Mirzaei Salehabadi S, Lavecchia J, Alberts NM, Krull KR, Ehrhardt MJ, et al. Suicidality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study. Cancer. 2020;126(24):5347-55. [PMID: 32964427]
53. 小児がん長期サバイバーの痛みのシステマティックレビュー
Schulte FSM, Patton M, Alberts NM, Kunin-Batson A, Olson-Bullis BA, Forbes C, et al. Pain in long-term survivors of childhood cancer: A systematic review of the current state of knowledge and a call to action from the Children's Oncology Group. Cancer. 2020;127(1):35-44. [PMID: 33112416]
54. 医療用大麻に関するケア体験のがん患者インタビュー
Braun IM, Nayak MM, Revette A, Wright AA, Chai PR, Yusufov M, et al. Cancer patients' experiences with medicinal cannabis-related care. Cancer. 2020;127(1):67-73. [PMID: 32986266]
55. 高齢者の身体活動、座位時間、心身の健康のがん罹患歴での比較
Rees-Punia E, Patel AV, Nocera JR, Chantaprasopsuk S, Demark-Wahnefried W, Leach CR, et al. Self-reported physical activity, sitting time, and mental and physical health among older cancer survivors compared with adults without a history of cancer. Cancer. 2020;127(1):115-23. [PMID: 33079415]
56. 若年女性がんサバイバーの離職に関連した物理的・心理的な経済的困窮
Meernik C, Kirchhoff AC, Anderson C, Edwards TP, Deal AM, Baggett CD, et al. Material and psychological financial hardship related to employment disruption among female adolescent and young adult cancer survivors. Cancer. 2020;127(1):137-48. [PMID: 33043464]
57. 高齢進行がん患者と家族での予後認識の一致
Loh KP, Soto Perez de Celis E, Duberstein PR, Culakova E, Epstein RM, Xu H, et al. Patient and caregiver agreement on prognosis estimates for older adults with advanced cancer. Cancer. 2020;127(1):149-59. [PMID: 33036063]
58. 泌尿器手術後のオピオイド鎮痛薬処方に対する行動療法の医療者介入
Jacobs BL, Rogers D, Yabes JG, Bandari J, Ayyash OM, Maganty A, et al. Large reduction in opioid prescribing by a multipronged behavioral intervention after major urologic surgery. Cancer. 2021;127(2):257-65. [PMID: 33002197]
59. 小児がん長期サバイバーの遺伝的変異とBMI
Richard MA, Brown AL, Belmont JW, Scheurer ME, Arroyo VM, Foster KL, et al. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer. 2021;127(2):310-8. [PMID: 33048379]
60. 悪性黒色腫患者の神経学的症状の総説
Cohen JV, Wang N, Venur VA, Hadfield MJ, Cahill DP, Oh K, et al. Neurologic complications of melanoma. Cancer. 2020;126(3):477-86. [PMID: 31725902]
61. 乳がん治療前の妊孕性温存の生存期間への影響
Letourneau JM, Wald K, Sinha N, Juarez-Hernandez F, Harris E, Cedars MI, et al. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020;126(3):487-95. [PMID: 31639215]
62. 血液がん患者とのケア目標の話し合いと終末期医療の関連
Odejide OO, Uno H, Murillo A, Tulsky JA, Abel GA. Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization. Cancer. 2020;126(3):515-22. [PMID: 31593321]
63. 手術を受ける高齢がん患者の精神健康リスクのスクリーニング
Trevino KM, Nelson CJ, Saracino RM, Korc-Grodzicki B, Sarraf S, Shahrokni A. Is screening for psychosocial risk factors associated with mental health care in older adults with cancer undergoing surgery? Cancer. 2020;126(3):602-10. [PMID: 31626346]
64. 進行期悪性黒色腫患者のQOLの推移
Kandel M, Dalle S, Bardet A, Allayous C, Mortier L, Dutriaux C, et al. Quality-of-life assessment in French patients with metastatic melanoma in real life. Cancer. 2020;126(3):611-8. [PMID: 31639198]
65. 小児がん長期サバイバーの健康行動の促進・増悪因子
Ford JS, Tonorezos ES, Mertens AC, Hudson MM, Casillas J, Foster BM, et al. Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 2020;126(3):619-27. [PMID: 31626337]
66. 小児白血病長期サバイバーの運動能力と認知機能の関連
Phillips NS, Howell CR, Lanctot JQ, Partin RE, Pui CH, Hudson MM, et al. Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort. Cancer. 2020;126(3):640-8. [PMID: 31631333]
67. 小児がんサバイバーの健康管理における併存疾患の影響
Harrington RL, Qato DM, Antoon JW, Caskey RN, Schumock GT, Lee TA. Impact of multimorbidity subgroups on the health care use of early pediatric cancer survivors. Cancer. 2020;126(3):649-58. [PMID: 31639197]
68. AYA世代がん患者の心血管疾患リスク
de Fine Licht S, Maraldo MV, Specht L, Nielsen TT, Winther JF, Rugbjerg K. Risk factors for cardiovascular disease in 5-year survivors of adolescent and young adult cancer: A Danish population-based cohort study. Cancer. 2020;126(3):659-69. [PMID: 31714589]
69. 乳がん患者対象のコーチングや情報提供のオンライン教育介入の症状緩和の効果
Im EO, Kim S, Yang YL, Chee W. The efficacy of a technology-based information and coaching/support program on pain and symptoms in Asian American survivors of breast cancer. Cancer. 2020;126(3):670- 80. [PMID: 31714598]
70. 小児がん患者と医療者のコミュニケーションの質的研究のシステマティックレビュー
Lin B, Gutman T, Hanson CS, Ju A, Manera K, Butow P, et al. Communication during childhood cancer: Systematic review of patient perspectives. Cancer. 2020;126(4):701-16. [PMID: 31821552]
71. 高齢乳がん患者の長期的なオピオイド鎮痛薬使用
Roberts AW, Fergestrom N, Neuner JM, Winn AN. New-onset persistent opioid use following breast cancer treatment in older adult women. Cancer. 2020;126(4):814-22. [PMID: 31846054]
72. 奇跡に関する宗教的信念のがん進行の説明後の予後認識への影響
George LS, Balboni TA, Maciejewski PK, Epstein AS, Prigerson HG. "My doctor says the cancer is worse, but I believe in miracles"-When religious belief in miracles diminishes the impact of news of cancer progression on change in prognostic understanding. Cancer. 2020;126(4):832-9. [PMID: 31658374]
73. がんサバイバーでの座位での活動と健康アウトカムの関連のシステマティックレビュー
Swain CTV, Nguyen NH, Eagles T, Vallance JK, Boyle T, Lahart IM, et al. Postdiagnosis sedentary behavior and health outcomes in cancer survivors: A systematic review and meta-analysis. Cancer. 2020;126(4):861-9. [PMID: 31714596]
74. 小児がん長期サバイバーでの糖尿病
Williams HE, Howell CR, Chemaitilly W, Wilson CL, Karol SE, Nolan VG, et al. Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study. Cancer. 2020;126(4):870-8. [PMID: 31714590]
75. 頭頚部がんサバイバーの呼吸器疾患リスク
Kawakita D, Abdelaziz S, Chen Y, Rowe K, Snyder J, Fraser A, et al. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study. Cancer. 2020;126(4):879-85. [PMID: 31721181]
76. 貧困にあるAYA世代がん患者の終末期医療
Roeland EJ, Lindley LC, Gilbertson-White S, Saeidzadeh S, Currie ER, Friedman S, et al. End-of-life care among adolescent and young adult patients with cancer living in poverty. Cancer. 2020;126(4):886-93. [PMID: 31724747]

Close